Literature DB >> 12639255

Performance analysis of a rapid HPLC determination with the solvent demixing extraction of HIV antiproteases and efavirenz in plasma.

M Cociglio1, D Hillaire-Buys, H Peyrière, R Alric.   

Abstract

A rapid and simple high-performance liquid chromatographic method without internal standardization is evaluated for the drug-level monitoring of most marketed antiproteases and efavirenz. Following plasma deproteinization with acetonitrile, the analytes are extracted into the solvent while it is demixed by the addition of a saturating amount of neutral salt. The organic supernatant is diluted by half with water up to the polarity of the mobile phase before being injected. The isocratic mobile phase is unbuffered water-acetonitrile (52:48), and the stationary phase is LiChrospher 100 RP-8 (5 microm). Analytes are eluted between 4 min (amprenavir and indinavir) and 20 min (nelfinavir). A spreadsheet program including analysis of variance (ANOVA) and regression is used for both the overall validation of milligrams-per-liter determinations and the performance evaluation of analytical steps from chromatographic raw data. Extraction shows acceptable 5% repeatability and nearly 100% recovery, although it is somewhat concentration-dependent. The calibration function is better fitted by bilogarithmic than arithmetical regression, and the ANOVA of raw data is found quite predictive of the quality of the final determinations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639255     DOI: 10.1093/chromsci/41.2.80

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  3 in total

1.  Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial.

Authors:  Boubacar Nacro; Emmanuelle Zoure; Hervé Hien; Hassane Tamboura; François Rouet; Adama Ouiminga; Ali Drabo; Souleymane Yameogo; Alain Hien; Hélène Peyriere; Olivier Mathieu; Deborah Hirt; Jean-Marc Treluyer; Joëlle Nicolas; Vincent Foulongne; Michel Segondy; Philippe van de Perre; Serge Diagbouga; Philippe Msellati
Journal:  Bull World Health Organ       Date:  2011-04-06       Impact factor: 9.408

2.  Pharmacokinetics of Efavirenz at a High Dose of 25 Milligrams per Kilogram per Day in Children 2 to 3 Years Old.

Authors:  Claire Pressiat; Madeleine Amorissani-Folquet; Caroline Yonaba; Jean-Marc Treluyer; Désiré Lucien Dahourou; François Eboua; Stéphane Blanche; Véronique Mea-Assande; Naïm Bouazza; Frantz Foissac; Karen Malateste; Sylvie Ouedraogo; Gabrielle Lui; Valériane Leroy; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

3.  Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children?

Authors:  Déborah Hirt; Saik Urien; Mathieu Olivier; Hélène Peyrière; Boubacar Nacro; Serge Diagbouga; Emmanuelle Zoure; François Rouet; Hervé Hien; Philippe Msellati; Philippe Van De Perre; Jean-Marc Tréluyer
Journal:  Antimicrob Agents Chemother       Date:  2009-07-27       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.